Improving Global Health

VTC Researcher in Bangladesh holding baby with motherFaculty researchers at the Vaccine Testing Center (VTC) study human vaccines with the goal of understanding and preventing infectious diseases around the globe. The VTC is in the Department of Microbiology and Molecular Genetics, which bridges both the University of Vermont College of Agriculture and Life Sciences and the Larner College of Medicine.

Our team is particularly interested in new vaccines with the potential to prevent or control infectious diseases in developing countries. We are a diverse team of clinicians, study coordinators, scientists, and laboratory personnel. Volunteers are critical to our work and our human research studies are designed and performed with rigorous oversight and safety.

Volunteer

Help Your Global Community defeat Polio. Volunteer!

Want to help your global community? 

Healthy Volunteers age 18-45 needed for a research study to help test a Polio Vaccine. 1 year, outpatient study. Up to $440 compensation. Try out our online Polio study pre-screen to see if you might qualify.

To learn more, contact us about this or ongoing pre-study screenings: 

Volunteers are a critical part of our research and their contributions save lives around the world every day. Thank you! 

Research 

Lab Tech looking in microscope

The Vaccine Testing Center's team of scientists and researchers are committed to solving the world’s most pressing infectious disease challenges. Our research spans the translational spectrum from lab-based human immunology to domestic clinical trials to large-scale international field research. Together with national and international collaborators and local volunteers, we help develop vaccines to address global infectious diseases, including rotavirus, cholera, dengue and other flaviviruses. More VTC research.

News

Benjamin Lee MD Headshot

TGIR: $12.3 million Award Announced

The Department of Microbiology & Molecular Genetics, the University of Vermont Larner College of Medicine are pleased to announce the receipt of a $12.3 million award for a new Center of Biomedical Research Excellence (COBRE) called the “Translational Global Infectious Disease Research Center” (TGIR). The TGIR will join together two traditionally distinct groups of scientists to develop innovative approaches to prevent and control infectious disease. The TGIR will be housed within MMG and will be led by MMG Chair and VTC Director Beth Kirkpatrick, MD along with Chris Huston, MD and Jason Bates, PhD.

News coverage: WAMC Radio interview, WCAX and Fox44 MyChamplainValley coverage. Learn more or go to the TGIR website.

See our news archives.

 

VTC Director Beth Kirkpatrick, M.D. (from UVM's "Move Mountains" Campaign)

 

VTC Showcase

Mother holding her child in Dhaka, BangladeshPodcast feature: How we improve global health

MMG/Vaccine Testing Center Faculty Scientist Ross Colgate, PhD, MPH, recently met with UVMMC to talk about the global importance of the work we do and how it is changing lives for the better, especially for the world's children. Listen to the podcast or read the transcript.

Upcoming Seminars

MMG Seminar Series:

“Analysis of PARP1 and PARG in Glioblastoma”

Speaker: Delphine Quénet,Ph.D., Assistant Professor, Department of Biochemistry, The University of Vermont

Date: January 16, 2019
Time: 9:30am—10:30am
Place: Davis Auditorium

TGIR COBRE Seminar Series:

To be announced.

Donate Here